Literature DB >> 25830697

MULTIMODAL IMAGING FINDINGS AND MULTIMODAL VISION TESTING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Taku Sato1, Mihoko Suzuki, Sotaro Ooto, Richard F Spaide.   

Abstract

PURPOSE: To investigate the interactions among multimodal imaging findings and multimodal vision testing in neovascular age-related macular degeneration.
METHODS: Patients enrolled in a prospective study of neovascular age-related macular degeneration with at least 3 previous intravitreal anti-vascular endothelial growth factor injections. Each patient underwent multimodal fundus imaging including spectral domain optical coherence tomography and fundus autofluorescence, and multimodal vision testing, including visual acuity, contrast sensitivity, reading speed, and microperimetry.
RESULTS: There were 73 eyes of 49 consecutive patients enrolled. Generalized estimating equations' modelling showed that the significant independent predictors of visual acuity were the area of confluent hypoautofluorescence and involvement of the foveal center with either granular or confluent hypoautofluorescence (P < 0.001). Contrast sensitivity was negatively correlated with the area of confluent hypoautofluorescence (P < 0.001), involvement of the foveal center with granular hypoautofluorescence (P = 0.017), and subfoveal choroidal thickness (P = 0.042). The only significant predictor of reading speed was the size of confluent hypoautofluorescence (P < 0.001). The size of the defect in the ellipsoid zone (P < 0.001) and the presence of intraretinal fluid (P = 0.045) were correlated with microperimetry score.
CONCLUSION: Confluent absence of autofluorescence was a highly significant predictor of vision testing and serves as an easy parameter to obtain in patients with neovascular age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25830697     DOI: 10.1097/IAE.0000000000000505

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Fundus Autofluorescence and Clinical Applications.

Authors:  Cameron Pole; Hossein Ameri
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

Review 2.  Fundus autofluorescence imaging: systematic review of test accuracy for the diagnosis and monitoring of retinal conditions.

Authors:  G K Frampton; N Kalita; L Payne; J L Colquitt; E Loveman; S M Downes; A J Lotery
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

3.  Neurodegeneration, gliosis, and resolution of haemorrhage in neovascular age-related macular degeneration, a clinicopathologic correlation.

Authors:  Miaoling Li; Rosa Dolz-Marco; Jeffrey D Messinger; Daniela Ferrara; K Bailey Freund; Christine A Curcio
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

4.  Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in Microperimetry.

Authors:  Nicola K Cassels; John M Wild; Tom H Margrain; Chris Blyth; Victor Chong; Jennifer H Acton
Journal:  Transl Vis Sci Technol       Date:  2019-12-31       Impact factor: 3.283

5.  Long-Term Visual/Anatomic Outcome in Patients with Fovea-Involving Fibrovascular Pigment Epithelium Detachment Presenting Choroidal Neovascularization on Optical Coherence Tomography Angiography.

Authors:  Kyung Tae Kim; Hwanho Lee; Jin Young Kim; Suhwan Lee; Ju Byung Chae; Dong Yoon Kim
Journal:  J Clin Med       Date:  2020-06-15       Impact factor: 4.241

6.  Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice.

Authors:  Luciana de Sá Quirino-Makarczyk; Maria de Fátima Sainz Ugarte; Bruna Viana Vieira; Sérgio Kniggendorf; Caio Vinicius Saito Regatieri
Journal:  Int J Retina Vitreous       Date:  2020-05-14

7.  Detecting vision loss in intermediate age-related macular degeneration: A comparison of visual function tests.

Authors:  Susanne G Pondorfer; Manuel Heinemann; Maximilian W M Wintergerst; Maximilian Pfau; Annika L Strömer; Frank G Holz; Robert P Finger
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.